ArticleScientific reports2024

Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacy.

Yuanhang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.